Výsledky vyhledávání - "S P, Golitsyn"

Akademický článek

Cavutilide (Refralon) for pharmacological cardioversion of early recurrence atrial fibrillation and flutter in blanking period after pulmonary veins isolation

Autor: M. A. Zelberg, N. Yu. Mironov, Kh. M. Dzaurova, Yu. A. Yuricheva, E. B. Maykov, P. S. Novikov, D. A. Gagloeva, M. A. Krimukova, S. F. Sokolov, S. P. Golitsyn

Publikováno v: Евразийский Кардиологический Журнал, Vol 0, Iss 2, Pp 86-95 (2024)

Objective. Evaluate efficacy and safety of cavutilide (Refralon) for pharmacological cardioversion in patients with recurrent atrial fibrillation and flutter (AF/AFL), in 90days blanking period of catheter ablation.Materials and methods. included 56

Externí odkaz: https://doaj.org/article/22ac86e42166436abe584631dc932ef7

Zobrazit plný text záznamu

Akademický článek

Diagnostic criteria for proximal left bundle branch block and their significance in predicting the success of cardiac resynchronization therapy

Autor: E. M. Rimskaya, S. Yu. Kashtanova, Kh. F. Salami, E. V. Kukharchuk, T. A. Malkina, S. A. Gaman, A. E. Komlev, N. A. Mironova, O. V. Stukalova, T. E. Imaev, R. S. Akchurin, S. P. Golitsyn

Publikováno v: Российский кардиологический журнал, Vol 28, Iss 8 (2023)

Aim. To develop diagnostic criteria for proximal left bundle branch block (LBBB) based on non-invasive methods and to determine the significance of these criteria in predicting the effect of cardiac resynchronization therapy (CRT).Material and method

Externí odkaz: https://doaj.org/article/d128e289c88e411781bb0e454870a853

Zobrazit plný text záznamu

Akademický článek

Eurasian association of cardiology (EAC) guidelines for the prevention and treatment of ventricular heart rhythm disorders and prevention of sudden cardiac death (2022)

Autor: S. P. Golitsyn, M. V. Kostyukevich, L. Yu. Lajovic, N. Yu. Mironov, N. A. Mironova, M. D. Utsumueva, D. R. Khusyainova, N. B. Shlevkov, B. Ch. Bazarov, V. A. Azizov, E. D. Dzhishambaev, N. U. Zakirov, D. B. Goncharik

Publikováno v: Евразийский Кардиологический Журнал, Vol 0, Iss 4, Pp 6-67 (2022)

The EAC Guidelines represent the views of the EAC, and were produced after careful consideration of the scientific and medical knowledge, and the evidence available at the time of their publication. The EAC is not responsible in the event of any cont

Externí odkaz: https://doaj.org/article/d7892ec6c7a64e76adb060b2723621cd

Zobrazit plný text záznamu

Akademický článek

Cardiovascular prevention 2022. Russian national guidelines

Publikováno v: Российский кардиологический журнал, Vol 28, Iss 5 (2023)

Russian Society of Cardiology, National Society of Preventive Cardiology

Externí odkaz: https://doaj.org/article/6af42f5729d84c1784d8c6fd021217b0

Zobrazit plný text záznamu

Akademický článek

Preliminary results of a prospective randomized study comparing the efficacy and safety of refralon and amiodarone in cardioversion in patients with paroxysmal atrial fibrillation and flutter

Autor: D. A. Gagloeva, Kh. M. Dzaurova, M. A. Zelberg, N. Yu. Mironov, Yu. A. Yuricheva, S. F. Sokolov, M. A. Krymukova, A. I. Salpagarova, L. O. Dulaev, D. V. Pevzner, S. P. Golitsyn

Publikováno v: Кардиоваскулярная терапия и профилактика, Vol 22, Iss 4 (2023)

Aim. To compare the efficacy and safety of chemical cardioversion (CCV) with refralon and amiodarone in patients with paroxysmal atrial fibrillation and flutter (AF/AFL).Material and methods. Fifty five patients (mean age, 65±11 years) with paroxy

Externí odkaz: https://doaj.org/article/9421170c3fc74df083e12f23e2bc4e63

Zobrazit plný text záznamu

Akademický článek

Safety and Effectiveness of Pharmacologic Conversion of Atrial Fibrillation and Flutter: Results of Multicenter Trial. Part II: Assessment of Safety

Autor: N. Yu. Mironov, Yu. A. Yuricheva, V. V. Vlodzyanovskiy, S. F. Sokolov, Kh. M. Dzaurova, S. P. Golitsyn, Yu. V. Shubik, M. V. Berman, M. M. Medvedev, A. E. Rivin, D. S. Parkhomchuk, A. E. Barybin, D. А. Balandin, R. E. Batalov, D. V. Terekhov, I. V. Evstifeev, I. R. Kildeev, O. V. Pyataeva, S. A. Zenin

Publikováno v: Рациональная фармакотерапия в кардиологии, Vol 17, Iss 5, Pp 668-673 (2021)

Aim. We aimed to assess safety and effectiveness of class III antiarrhythmic drug Refralon for conversion of atrial fibrillation (AFib) and flutter (AFl) in post-registration trial and to compare data of primary center (National medical research cent

Externí odkaz: https://doaj.org/article/fda3bc3bcec0409e89ef6af250af93a3

Zobrazit plný text záznamu

Akademický článek

Soluble suppression of tumorigenesis-2 (sST2), a new potential biomarker of response to cardiac resynchronization therapy and cardiac contractility modulation in patients with chronic heart failure

Autor: N. B. Shlevkov, A. Zh. Gasparyan, A. A. Zhambeev, H. F. Salami, E. V. Guseva, G. S. Tarasovskiy, T. V. Sharf, O. V. Stukalova, E. M. Gupalo, N. A. Mironova, A. A. Skvortsov, S. P. Golitsyn

Publikováno v: Alʹmanah Kliničeskoj Mediciny, Vol 49, Iss 2, Pp 99-112 (2021)

Background: According to numerous studies, from 30% to 50% of patients with chronic heart failure (CHF) are resistant to cardiac resynchronization therapy (CRT) and cardiac contractility modulation (CCM), despite their careful selection in accordance

Externí odkaz: https://doaj.org/article/c4cc16ca1a814101bb678afc707e4eb5

Zobrazit plný text záznamu

Akademický článek

Safety and Effectiveness of Pharmacologic Conversion of Atrial Fibrillation and Flutter: Results of Multicenter Trial. Part I: Study Rationale, Design and Assessment of Effectiveness

Autor: N. Yu. Mironov, Yu. A. Yuricheva, V. V. Vlodzyanovskiy, S. F. Sokolov, Kh. M. Dzaurova, S. P. Golitsyn, Yu. V. Shubik, M. V. Berman, M. M. Medvedev, A. E. Rivin, D. S. Parkhomchuk, A. E. Barybin, D. А. Balandin, R. E. Batalov, D. S. Terekhov, I. V. Evstifeev, I. R. Kildeev, O. V. Pyataeva, S. A. Zenin

Publikováno v: Рациональная фармакотерапия в кардиологии, Vol 17, Iss 2, Pp 193-199 (2021)

Externí odkaz: https://doaj.org/article/0f377f87549f4a628c7889891fa7039f

Zobrazit plný text záznamu

Akademický článek

Adherence and efficacy of long-term PAP therapy in patients with sleep-related breathing disorders associated with cardiac conduction disorders

Autor: E. M. Elfimova, O. O. Mikhailova, N. T. Khachatryan, A. Y. Litvin, I. E. Chazova, L. Y. Laiovich, T. A. Malkina, A. V. Pevzner, S. P. Golitsyn

Publikováno v: Терапевтический архив, Vol 92, Iss 9, Pp 39-43 (2020)

Aim.To study the effectiveness of prolonged use of PAP therapy (positive airway pressure therapy) in eliminating sleep respiratory disorders and associated cardiac conduction disturbances. Materials and methods.We included 21 patients who were exa

Externí odkaz: https://doaj.org/article/368279ae10d84b0d9cb8b7d0e087753e

Zobrazit plný text záznamu

Akademický článek

EURASIAN ASSOCIATION OF CARDIOLOGY (EAC)/ NATIONAL SOCIETY OF HEART FAILURE AND MYOCARDIAL DISEASE (NSHFMD) GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF CHRONIC HEART FAILURE (2020)

Autor: S. N. Tereshchenko, I. V. Zhirov, T. M. Uskach, M. A. Saidova, S. P. Golitsyn, E. M. Gupalo, S. N. Nasonova, O. Yu. Narusov, A. A. Safiullina, A. S. Tereshchenko, O. V. Stukalova

Publikováno v: Евразийский Кардиологический Журнал, Vol 0, Iss 3, Pp 6-76 (2020)

Disclaimer The EAC/NSHFMD Guidelines represent the views of the EAC and NSHFMD, and were produced after careful consideration of the scientific and medical knowledge, and the evidence available at the time of their publication. The EAC and NSHFMD is

Externí odkaz: https://doaj.org/article/87954bd81e52402b8664af779cc79fff

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání